Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jun;41(6):1331–1334. doi: 10.1128/aac.41.6.1331

In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

N Miyashita 1, Y Niki 1, T Kishimoto 1, M Nakajima 1, T Matsushima 1
PMCID: PMC163910  PMID: 9174194

Abstract

The in vitro and in vivo activities of AM-1155, a new quinolone, against Chlamydia spp. were investigated. The MIC of AM-1155 for 10 standard strains of different Chlamydia spp. and 25 wild-type strains of Chlamydia pneumoniae isolated in Japan, which were morphologically different from clinical isolates from the United States, ranged from 0.063 to 0.125 microg/ml. Its activity was almost the same as those of sparfloxacin and tosufloxacin and was 4 and 16 times superior to those of levofloxacin and ciprofloxacin, respectively, but lower than those of clarithromycin and minocycline (range for each, 0.016 to 0.031 microg/ml). The minimal chlamydiacidal concentration of AM-1155 ranged from 0.063 to 0.125 microg/ml, while those of clarithromycin and minocycline ranged from 0.016 to 0.031 microg/ml and 0.016 to 0.063 microg/ml, respectively. The therapeutic effect of a 7-day course of AM-1155 at doses of 5 and 10 mg/kg of body weight administered orally twice daily to mice with experimental Chlamydia psittaci pneumonia was excellent, with a 100% survival rate at 21 days after infection. The efficacy was equal to those of clarithromycin and minocycline and higher than those of ciprofloxacin and ofloxacin.

Full Text

The Full Text of this article is available as a PDF (146.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Emre U., Roblin P. M., Gelling M., Dumornay W., Rao M., Hammerschlag M. R., Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994 Jul;148(7):727–732. doi: 10.1001/archpedi.1994.02170070065013. [DOI] [PubMed] [Google Scholar]
  2. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  3. Grayston J. T., Kuo C. C., Wang S. P., Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986 Jul 17;315(3):161–168. doi: 10.1056/NEJM198607173150305. [DOI] [PubMed] [Google Scholar]
  4. Grayston J. T., Wang S. P., Kuo C. C., Campbell L. A. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):191–202. doi: 10.1007/BF01965260. [DOI] [PubMed] [Google Scholar]
  5. Hammerschlag M. R., Hyman C. L., Roblin P. M. In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1992 Mar;36(3):682–683. doi: 10.1128/aac.36.3.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hammerschlag M. R., Qumei K. K., Roblin P. M. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1992 Jul;36(7):1573–1574. doi: 10.1128/aac.36.7.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hosaka M., Kinoshita S., Toyama A., Otsuki M., Nishino T. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemother. 1995 Aug;36(2):293–301. doi: 10.1093/jac/36.2.293. [DOI] [PubMed] [Google Scholar]
  8. Hosaka M., Yasue T., Fukuda H., Tomizawa H., Aoyama H., Hirai K. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother. 1992 Oct;36(10):2108–2117. doi: 10.1128/aac.36.10.2108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ishida K., Kaku M., Irifune K., Mizukane R., Takemura H., Yoshida R., Tanaka H., Usui T., Tomono K., Suyama N. In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae. J Antimicrob Chemother. 1994 Dec;34(6):875–883. doi: 10.1093/jac/34.6.875. [DOI] [PubMed] [Google Scholar]
  10. Kishimoto T., Soejima R. Current topics of chlamydial respiratory tract infections--special reference to the epidemiology and clinical findings of Chlamydia pneumoniae infections in Japan. Intern Med. 1993 Dec;32(12):934–937. doi: 10.2169/internalmedicine.32.934. [DOI] [PubMed] [Google Scholar]
  11. Kuo C. C., Grayston J. T. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother. 1988 Feb;32(2):257–258. doi: 10.1128/aac.32.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miyashita N., Kanamoto Y., Matsumoto A. The morphology of Chlamydia pneumoniae. J Med Microbiol. 1993 Jun;38(6):418–425. doi: 10.1099/00222615-38-6-418. [DOI] [PubMed] [Google Scholar]
  13. Miyashita N., Kubota Y., Kimura M., Nakajima M., Niki Y., Soejima R., Matsumoto A. Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man. Microbiol Immunol. 1994;38(11):857–864. doi: 10.1111/j.1348-0421.1994.tb02138.x. [DOI] [PubMed] [Google Scholar]
  14. Miyashita N., Matsumoto A., Kubota Y., Nakajima M., Niki Y., Matsushima T. Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis. Microbiol Immunol. 1996;40(8):547–552. doi: 10.1111/j.1348-0421.1996.tb01107.x. [DOI] [PubMed] [Google Scholar]
  15. Nakashima M., Uematsu T., Kosuge K., Kusajima H., Ooie T., Masuda Y., Ishida R., Uchida H. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother. 1995 Dec;39(12):2635–2640. doi: 10.1128/aac.39.12.2635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tomioka H., Saito H., Sato K. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Antimicrob Agents Chemother. 1993 Jun;37(6):1259–1263. doi: 10.1128/aac.37.6.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wakabayashi E., Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother. 1994 Mar;38(3):594–601. doi: 10.1128/aac.38.3.594. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES